NM_001355436.2:c.5535C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.5535C>T​(p.Leu1845Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0701 in 1,609,008 control chromosomes in the GnomAD database, including 4,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 292 hom., cov: 33)
Exomes 𝑓: 0.072 ( 4123 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0500

Publications

10 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 14-64772598-G-A is Benign according to our data. Variant chr14-64772598-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.05 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0815 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.5535C>T p.Leu1845Leu synonymous_variant Exon 26 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.5535C>T p.Leu1845Leu synonymous_variant Exon 26 of 36 NM_001355436.2 ENSP00000495909.1 P11277-2
SPTBENST00000553938.5 linkc.1530C>T p.Leu510Leu synonymous_variant Exon 7 of 18 1 ENSP00000451324.1 H0YJE6
SPTBENST00000389722.7 linkc.5535C>T p.Leu1845Leu synonymous_variant Exon 25 of 35 2 ENSP00000374372.3 P11277-2
SPTBENST00000389720.4 linkc.5535C>T p.Leu1845Leu synonymous_variant Exon 26 of 32 5 ENSP00000374370.4 P11277-1

Frequencies

GnomAD3 genomes
AF:
0.0565
AC:
8602
AN:
152168
Hom.:
292
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0172
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0529
Gnomad ASJ
AF:
0.0550
Gnomad EAS
AF:
0.0194
Gnomad SAS
AF:
0.0290
Gnomad FIN
AF:
0.0785
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0833
Gnomad OTH
AF:
0.0435
GnomAD2 exomes
AF:
0.0595
AC:
14583
AN:
245264
AF XY:
0.0599
show subpopulations
Gnomad AFR exome
AF:
0.0149
Gnomad AMR exome
AF:
0.0410
Gnomad ASJ exome
AF:
0.0508
Gnomad EAS exome
AF:
0.0264
Gnomad FIN exome
AF:
0.0763
Gnomad NFE exome
AF:
0.0828
Gnomad OTH exome
AF:
0.0596
GnomAD4 exome
AF:
0.0715
AC:
104186
AN:
1456722
Hom.:
4123
Cov.:
33
AF XY:
0.0708
AC XY:
51303
AN XY:
725100
show subpopulations
African (AFR)
AF:
0.0138
AC:
463
AN:
33472
American (AMR)
AF:
0.0438
AC:
1956
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0518
AC:
1354
AN:
26120
East Asian (EAS)
AF:
0.0168
AC:
665
AN:
39694
South Asian (SAS)
AF:
0.0308
AC:
2655
AN:
86238
European-Finnish (FIN)
AF:
0.0783
AC:
3813
AN:
48714
Middle Eastern (MID)
AF:
0.0381
AC:
214
AN:
5610
European-Non Finnish (NFE)
AF:
0.0802
AC:
89135
AN:
1111860
Other (OTH)
AF:
0.0652
AC:
3931
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
6052
12105
18157
24210
30262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3112
6224
9336
12448
15560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0565
AC:
8603
AN:
152286
Hom.:
292
Cov.:
33
AF XY:
0.0565
AC XY:
4208
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0172
AC:
715
AN:
41576
American (AMR)
AF:
0.0529
AC:
809
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0550
AC:
191
AN:
3472
East Asian (EAS)
AF:
0.0195
AC:
101
AN:
5182
South Asian (SAS)
AF:
0.0288
AC:
139
AN:
4826
European-Finnish (FIN)
AF:
0.0785
AC:
833
AN:
10608
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0833
AC:
5662
AN:
67998
Other (OTH)
AF:
0.0440
AC:
93
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
408
816
1225
1633
2041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0725
Hom.:
259
Bravo
AF:
0.0522
Asia WGS
AF:
0.0560
AC:
194
AN:
3478
EpiCase
AF:
0.0749
EpiControl
AF:
0.0748

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
12
DANN
Benign
0.93
PhyloP100
0.050
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17180252; hg19: chr14-65239316; API